Evidence map›Paper›PMID 27365490›Full record

Trial reportHaematologica2016

Bone healing in multiple myeloma: a prospective evaluation of the impact of first-line anti-myeloma treatment.

Maja Hinge, Kristian T Andersen, Thomas Lund, Henrik B Jørgensen, Paw C Holdgaard, Tina E Ormstrup, Lone L Østergaard, Torben Plesner

Abstract readClinical Trial, Phase IILetter
In one paragraph

Trial report in Haematologica, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Exercise for myeloma patients with bone disease: a scoping review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Pathogenic Mechanisms of Myeloma Bone Disease and Possible Roles for NRF2.International journal of molecular sciences · 2020
    Review
  6. Article
  7. Review
  8. Extensive Remineralization of Large Pelvic Lytic Lesions Following Total Therapy Treatment in Patients With Multiple Myeloma.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Maja HingeDepartment of Internal Medicine, Division of Hematology, Vejle Hospital, Institute of Regional Health Research, University of Southern Denmark, Denmark maja.hinge@rsyd.dk.
Kristian T AndersenDepartment of Internal Medicine, Division of Hematology, Vejle Hospital, Institute of Regional Health Research, University of Southern Denmark, Denmark.
Thomas LundDepartment of Hematology, Odense University Hospital, Denmark.
Henrik B JørgensenDepartment of Nuclear Medicine, Vejle Hospital, Denmark.
Paw C HoldgaardDepartment of Nuclear Medicine, Vejle Hospital, Denmark.
Tina E OrmstrupDepartment of Radiology, Vejle Hospital, Denmark.
Lone L ØstergaardDepartment of Radiology, Vejle Hospital, Denmark.
Torben PlesnerDepartment of Internal Medicine, Division of Hematology, Vejle Hospital, Institute of Regional Health Research, University of Southern Denmark, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic Combined Chemotherapy ProtocolsFollow-Up StudiesHumansMultiple MyelomaOsteogenesisOsteolysisProspective StudiesTomography, Emission-Computed, Single-PhotonTreatment Outcomebone diseasebone markerbone sclerosismultiple myelomaosteolytic lesion

Identifiers

PMID27365490
PMCPMC5046665

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.